Skip to content

Clinical trials

Malaria, Falciparum trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Malaria, Falciparum Country / region: Australia Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20102
20141
20151
20161
20171
20221
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Not yet recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Medicines for Malaria Venture4
sigma-tau i.f.r. S.p.A.2
Guangzhou Patronus Biotech Co., Ltd.1
Merck KGaA, Darmstadt, Germany1
Novartis Pharmaceuticals1
University of Melbourne1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Malaria, Falciparum10
Malaria5
Parasitemia2
Parasitic Diseases2
Protozoan Infections2
Infections1
Inflammation1
Malaria, Vivax1
Pathologic Processes1
Systemic Inflammatory Response Syndrome1

Trials

Showing 51 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.